Cambridge NanoTech Signs Agreements to Sell and Service ALD Equipments in Asia

Cambridge NanoTech, the world leader in Atomic Layer Deposition (ALD) equipment for research and industry, today announced that it has signed agreements with Start Science of Beijing, China and CORREMAX International of Taipei, Taiwan to sell and service their full line of ALD equipment in those countries. Cambridge NanoTech already has several systems installed in China and Taiwan, being used for research, development and production.

“We are very pleased to be represented by these two outstanding companies in such an important region of the world,” said Ray Ritter, Chief Operating Officer for Cambridge NanoTech. “We are confident that their many years of experience selling and supporting high-tech instruments, combined with their expertise and integrity, will be key in expanding our business in Southeast Asia.”

“Cambridge NanoTech’s systems will be an excellent addition to our portfolio of innovative, advanced instruments and equipment for the scientific and industrial research sectors in China,” said Mr. Dongjun Wang, President of Start Science. “We believe there is a tremendous market opportunity in China for ALD solutions and we expect to grow this market significantly.”

“Our experienced and knowledgeable team is already supporting Cambridge NanoTech systems running in production in Taiwan,” said Mr. George Yen, Vice General Manager of CORREMAX International. “We believe the market for ALD systems in Taiwan, for both R&D and production, is just in its infancy. We are thrilled to be at the forefront of such an exciting opportunity.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.